Publicaciones en colaboración con investigadores/as de Hospital Universitario San Juan de Alicante (44)

2022

  1. A comparison of front-line oral anticoagulants for the treatment of non-valvular atrial fibrillation: effectiveness and safety of direct oral anticoagulants in the FANTASIIA registry

    Expert Opinion on Pharmacotherapy, Vol. 23, Núm. 12, pp. 1457-1465

  2. Current trends on antithrombotic therapy

    REC: CardioClinics

  3. Impact of Integrated Care Management on Clinical Outcomes in Atrial Fibrillation Patients: A Report From the FANTASIIA Registry

    Frontiers in Cardiovascular Medicine, Vol. 9

2021

  1. Baseline CHA2DS2-VASc score and prognosis in octogenarians with non-ST segment elevation acute coronary syndrome

    International Journal of Clinical Practice, Vol. 75, Núm. 6

  2. Comorbidity burden and revascularization benefit in elderly patients with acute coronary syndrome

    Revista Espanola de Cardiologia, Vol. 74, Núm. 9, pp. 765-772

  3. Impact of comorbidities in the decision of using invasive management in elderly patients with NSTEACS

    REC: Interventional Cardiology, Vol. 3, Núm. 1, pp. 15-20

  4. Peripheral artery disease and clinical outcomes in patients with atrial fibrillation: A report from the FANTASIIA registry

    European Journal of Clinical Investigation, Vol. 51, Núm. 4

  5. Prognosis impact of diabetes in elderly women and men with non-st elevation acute coronary syndrome

    Journal of Clinical Medicine, Vol. 10, Núm. 19

  6. Relationship between multimorbidity and outcomes in atrial fibrillation

    Experimental Gerontology, Vol. 153

2020

  1. Association of Body Mass Index With Clinical Outcomes in Patients With Atrial Fibrillation: A Report From the FANTASIIA Registry

    Journal of the American Heart Association, Vol. 9, Núm. 1

  2. Direct Anticoagulants Versus Vitamin K Antagonists in Patients Aged 80 Years or Older With Atrial Fibrillation in a “Real-world” Nationwide Registry: Insights From the FANTASIIA Study

    Journal of Cardiovascular Pharmacology and Therapeutics, Vol. 25, Núm. 4, pp. 316-323

  3. Direct oral anticoagulants versus vitamin K antagonists in real-world patients with nonvalvular atrial fibrillation. The FANTASIIA study

    Revista Espanola de Cardiologia, Vol. 73, Núm. 1, pp. 14-20

  4. FRAIL Scale also Predicts Long-Term Outcomes in Older Patients With Acute Coronary Syndromes

    Journal of the American Medical Directors Association, Vol. 21, Núm. 5, pp. 683-687.e1

  5. INR during stroke and bleeding in patients with atrial fibrillation and on vitamin K antagonists

    REC: CardioClinics, Vol. 55, Núm. 3, pp. 131-138

  6. Influence of sex on long-term prognosis in patients with atrial fibrillation treated with oral anticoagulants. Results from the prospective, nationwide FANTASIIA study

    European Journal of Internal Medicine, Vol. 78, pp. 63-68

  7. Prognostic impact of anemia according to frailty status in elderly patients with acute coronary syndromes

    Journal of Cardiovascular Medicine, Vol. 21, Núm. 1, pp. 27-33

  8. Relationship of adverse events to quality of anticoagulation control in atrial fibrillation patients with diabetes: real-world data from the FANTASIIA Registry

    Annals of Medicine, Vol. 52, Núm. 6, pp. 300-309

2019

  1. Atrial Fibrillation in Active Cancer Patients: Expert Position Paper and Recommendations

    Revista Espanola de Cardiologia, Vol. 72, Núm. 9, pp. 749-759

  2. Diabetes mellitus, frailty and prognosis in very elderly patients with acute coronary syndromes

    Aging Clinical and Experimental Research, Vol. 31, Núm. 11, pp. 1635-1643

  3. Mitral Regurgitation and Prognosis After Non-ST-Segment Elevation Myocardial Infarction in Very Old Patients

    Journal of the American Geriatrics Society, Vol. 67, Núm. 8, pp. 1641-1648